Corcept (CORT) Skyrockets 1,534% in 10 Years
Corcept Therapeutics Inc. (NASDAQ:CORT) is a commercial-stage pharmaceutical company founded in 1998 and headquartered in Menlo Park, California.…
Health Care ETF (XLV) Beats S&P 500 in 15 of the Last 25 Years
The Health Care Select Sector SPDR Fund (NYSE:XLV) is one of the most widely recognized exchange-traded funds providing…
Cadrenal (CVKD) Targeted at $30 After Acquiring Phase 2-Ready Frunexian
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a clinical-stage biopharmaceutical company focused on addressing critical unmet needs in cardiovascular medicine,…
Pfizer (PFE) Secures $70B R&D Push
Pfizer Inc. (NYSE:PFE) is one of the world’s most established and influential pharmaceutical companies, with a history spanning…
4D Molecular Therapeutics Insider Sells $19,256 as FDMT Surges 27% in a Week
4D Molecular Therapeutics Inc. (NASDAQ:FDMT) is a clinical-stage biopharmaceutical company headquartered in Emeryville, California, dedicated to developing next-generation…
Aurora Cannabis (ACB) Poised for Rebound With $309M Market Cap
Aurora Cannabis Inc. (NASDAQ:ACB) is one of the pioneering names in the global cannabis industry, headquartered in Edmonton,…
Aurinia Pharmaceuticals (AUPH) Hits $13.45 52-Week High After 80% Surge
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a biopharmaceutical company headquartered in Victoria, British Columbia, with a mission to transform…
Applied DNA (APDN) Lands $58M to Fuel Binance Token Bet
Applied DNA Sciences Inc. (NASDAQ:APDN) is a biotechnology company headquartered in Stony Brook, New York, with a long…
MoonLake (MLTX)’s Sonelokimab Crushes Phase 3 Goals With 35% Response Rate in HS
MoonLake Immunotherapeutics (NASDAQ:MLTX) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for inflammatory diseases with high…
Humana (HUM) Ordered to Pay $32 Million in Whistleblower Case
Humana Inc. (NYSE:HUM) headquartered in Louisville, Kentucky, is one of the largest health and well-being companies in the…
Johnson & Johnson (JNJ) is Up 22% in 2025
Johnson & Johnson is one of the most iconic healthcare companies in the world, with a history that…
Novo Nordisk (NVO) Surges as Ozempic and Wegovy Drive $48.5B in 2025 Sales
Novo Nordisk A/S (NYSE:NVO) is a global healthcare leader with more than a century of history, founded in…
Summit Therapeutics (SMMT) Up 14% YTD
Summit Therapeutics Inc. (NASDAQ:SMMT) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies…
Anavex (AVXL) Could Surge 300%—Analyst Reiterates $42 Price Target
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for central nervous…
bioAffinity (BIAF) Soars 52% After CyPath Lung Detects Stage 1A Cancer
bioAffinity Technologies, Inc. (NASDAQ: BIAF) is a biotechnology company committed to transforming the diagnosis and treatment of cancer…
Sarepta (SRPT) Crashes 76% in 6 Months, But Gained $4.1B Sales
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is a biotechnology company that has built its reputation as a global leader in…
Praxis (PRAX) Plunges 37% After Tremor Drug Ulixacaltamide Trial Stopped for Futility
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous…
Jazz Pharma (JAZZ) Reports $905M R&D Charge, $505M Net Loss in Q2 2025
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, with a strong operational presence…